Physician profile
Lucy Bolerjack
NPI 1346815875
$1,132.90
in general payments reported to CMS, 2019-2025
18 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $359 · 2023: $268 · 2024: $240 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $151.93 | 2022 | |
| Philips North America LLC | $119.27 | 2024 | (Bh4) Igt Devices Undivided |
| Minerva Surgical, INC | $118.43 | 2022-2023 | |
| Bard Peripheral Vascular, INC. | $107.00 | 2022 | |
| Hologic Sales and Service, LLC | $106.48 | 2024-2025 | Aptima, Myosure Tissue Removal Device, Novasure |
| Coloplast Corp | $104.22 | 2022-2025 | |
| Medicem INC. | $99.92 | 2023 | |
| Astellas Pharma US INC | $78.96 | 2023 | Veozah |
| Mayne Pharma Commercial LLC | $48.27 | 2025 | |
| Baxter Healthcare | $39.35 | 2024 | Perclot |
| Sumitomo Pharma America, INC. | $35.24 | 2025 | Myfembree |
| Medtronic, INC. | $22.67 | 2023 | |
| Exeltis, USA INC. | $19.37 | 2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $19.20 | 2025 | |
| Urgo Medical North America, LLC | $18.80 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $17.70 | 2025 | Femlyv |
| Axonics, INC. | $14.19 | 2023 | Bulkamid |
| Abbvie INC. | $11.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Bolerjack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.